OvaScience


OvaScience’s Fertility Treatment Shows Promise

OvaScience (NASDAQ: OVAS) is still testing its Augment Treatment, but analysts seem optimistic about recent results. OvaScience focuses on developing fertility treatments.

H.C. Wainwright Significantly Raises OvaScience Price Target Following Investor Day

In a research report released today, H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts